A Comparative Study Evaluating the Quality of Life and Survival Outcomes in Patients Receiving Chemotherapy Versus Oral Tyrosine Kinase Inhibitor in the Third Line and Beyond Setting for Advanced NSCLC.
Noronha V, Menon NS, Patil VM, Chandrakanth MV, More S, Dhanawat A, Chowdhary OR, Singh AC, Goud S, Shah S, Karuvandan N, Jobanputra KN, Shah DK, Shah MJ, Sarma R, Patel D, Joarder R, Kumar P, John A, Kaur J, Bagra S, Purandare N, Janu A, Mahajan A, Prabhash K.
Noronha V, et al. Among authors: joarder r.
JTO Clin Res Rep. 2023 Dec 18;5(1):100622. doi: 10.1016/j.jtocrr.2023.100622. eCollection 2024 Jan.
JTO Clin Res Rep. 2023.
PMID: 38292414
Free PMC article.